Article ID Journal Published Year Pages File Type
8630068 Diabetes Research and Clinical Practice 2018 24 Pages PDF
Abstract
The vast majority of patients with type 2 diabetes continue metformin after insulin initiation, consistent with guidelines. Other antihyperglycemics are frequently continued along with insulin, and further research is needed to determine which, if any, patients may benefit from this.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Endocrinology
Authors
, , , , ,